Inhibikase Therapeutics Issues Letter to Shareholders and Provides Update on Development Programs
GlobeNewswire
BOSTON and ATLANTA, April 18, 2024 (GLOBE NEWSWIRE) -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (Inhibikase or Company), a..
BOSTON and ATLANTA, April 18, 2024 (GLOBE NEWSWIRE) -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (Inhibikase or Company), a..
The NLP market is experiencing rapid growth, driven by the increasing demand for AI-powered solutions across various industries...
New York, Jan. 30, 2024 (GLOBE NEWSWIRE) -- According to Market.us, The Enterprise Data Management market size is expected to be..